About Me
Cardiologist
Data Scientist
Banerjee Lab
Projects
STIMULATE-ICP
The DISC Study
Publications
COVID-19
Blog
Contact
Educator
News
Publications
Publicatons
Publications
SEP
08
Machine learning-enhanced baseline risk prediction models for cancer therapy related cardiac dysfunction: a systematic review and critical appraisal of methodological quality
By:
Maria Sol Andres
on
SEP
08
CONCLUSION: Current ML-based models for predicting CTRCD remain underdeveloped for clinical use. The present findings highlight the need for further work to optimize models by incorporating rigorous study designs, with emphasis on methodological clarity, standardized outcome definitions, and external validation to improve reproducibility.
Read more >>
SEP
07
Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
By:
GBD 2023 Second-hand smoke Collaborators
on
SEP
07
BACKGROUND: Second-hand smoke (SHS) exposure remains a major source of morbidity and mortality among non-smokers. This study presents the first dedicated Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) publication to systematically quantify SHS prevalence and evaluate its effect as a global risk factor across a broader range of outcomes.
Read more >>
SEP
07
Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England
By:
Yogini V Chudasama
on
SEP
07
CONCLUSIONS: MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone. Findings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.
Read more >>
AUG
19
Central T cell tolerance from sparse peptide sampling
By:
Hannah V Meyer
on
AUG
19
Negative selection in the thymus limits autoimmunity by eliminating T cells that react strongly to self. Individual T cells, however, are only exposed to a small fraction of all self-peptides during their "training" in the thymus, and how tolerance is generalized to the remaining "test" self-peptides across peripheral tissues in the body remains an open question. We show that this can be achieved because the immune system satisfies two conditions necessary for generalization in machine learning...
Read more >>
AUG
12
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services
By:
Ashkan Dashtban
on
AUG
12
CONCLUSIONS: LC is associated with sustained increases in healthcare utilisation and costs in England and Wales. Our findings suggest that system-level service design may influence healthcare use and costs following COVID-19, warranting further evaluation of post-viral care models.
Read more >>
JUL
28
Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial
By:
STIMULATE-ICP Consortium
on
JUL
28
Combining multidisciplinary care plans into integrated care pathways (ICPs) is scalable, generalizable and effective for several long-term conditions, but not evaluated in Long COVID (LC). Our phase 3, cluster-randomized, multicenter clinical trial investigated the effectiveness of ICP interventions for LC. Recruitment of adults ≥18 years with LC was conducted in 6 National Health Service LC clinics in England with specialist ICPs. The intervention arms were (i) multi-organ magnetic resonance...
Read more >>
JUL
11
Scalable risk stratification of undiagnosed heart failure using routine health data and its association with imaging phenotypes and outcomes
By:
Yoko M Nakao
on
JUL
11
Late diagnosis of Heart failure (HF) is associated with worse outcomes. We aimed to develop a scalable tool to identify those at high risk of undiagnosed HF using routine electronic health records (EHR). We developed and internally validated a logistic regression (FIND-HF) model for incident HF diagnosis within one year in United Kingdom primary care EHRs (CPRD-Aurum, n=3 520 186), with good prediction performance (area under the receiver operating characteristic curve (AUC) 0.79), equal to more...
Read more >>
JUL
08
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
By:
STIMULATE-ICP consortium
on
JUL
08
BACKGROUND: Post-acute sequelae of COVID-19 or post-COVID-19 condition (also known as long COVID) affects 1-5% of adults globally, most commonly with fatigue, and no evidence-based therapies are available. We aimed to evaluate the efficacy of repurposed medications in fatigue management in adults with long COVID.
Read more >>
JUL
06
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
By:
Mary Norine Walsh
on
JUL
06
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global surveillance, and prevention programs. To address this, several cardiac societies and foundations convened to standardize the definition of HF in 2021 and designated stage B or pre-HF to identify individuals at risk of developing HF. In subsequent years, substantial progress and changes have been made in...
Read more >>
JUN
29
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
By:
Mary Norine Walsh
on
JUN
29
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global surveillance, and prevention programs. To address this, several cardiac societies and foundations convened to standardize the definition of HF in 2021 and designated stage B or pre-HF to identify individuals at risk of developing HF. In subsequent years, substantial progress and changes have been made in...
Read more >>
More Posts
Create your business website with
Website Builder.
Share by: